105 related articles for article (PubMed ID: 8204521)
1. The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy.
Hagemeister FB; Purugganan R; Podoloff DA; Hess M; Rodriguez MA; McLaughlin P; Swan F; Romaguera JE; Cabanillas F
Ann Oncol; 1994; 5 Suppl 2():59-63. PubMed ID: 8204521
[TBL] [Abstract][Full Text] [Related]
2. NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
Hagemeister FB; Cabanillas F; Velásquez WS; Meistrich ML; Liang JC; McLaughlin P; Redman JR; Romaguera JE; Rodríguez MA; Swan F
Semin Oncol; 1990 Dec; 17(6 Suppl 10):34-8; discussion 38-40. PubMed ID: 2259922
[TBL] [Abstract][Full Text] [Related]
3. Treatment of stage I and II Hodgkin's disease with NOVP (mitoxantrone, vincristine, vinblastine, prednisone) and radiotherapy.
Tormo M; Terol MJ; Marugán I; Solano C; Benet I; Garcia-Conde J
Leuk Lymphoma; 1999 Jun; 34(1-2):137-42. PubMed ID: 10350341
[TBL] [Abstract][Full Text] [Related]
4. NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.
Hagemeister FB; Fuller L; McLaughlin P; Rodriguez M; Romaguera J; Swan F; Cabanillas F
Ann Oncol; 1992 Sep; 3 Suppl 4():87-90. PubMed ID: 1450086
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
Preti A; Hagemeister FB; McLaughlin P; Swan F; Rodriguez A; Besa P; Cox JD; Allen PK; Cabanillas F
Ann Oncol; 1994; 5 Suppl 2():97-100. PubMed ID: 7515653
[TBL] [Abstract][Full Text] [Related]
6. Are alkylating agents a necessary component in the therapy of Hodgkin's disease.
Hagemeister FB
Leuk Lymphoma; 1993; 10 Suppl():91-7. PubMed ID: 7683230
[TBL] [Abstract][Full Text] [Related]
7. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
Mjaaland I; Ganser D; Freitag EM; Bohndorf W
Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
[TBL] [Abstract][Full Text] [Related]
8. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
[TBL] [Abstract][Full Text] [Related]
9. Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
Meistrich ML; Wilson G; Mathur K; Fuller LM; Rodriguez MA; McLaughlin P; Romaguera JE; Cabanillas FF; Ha CS; Lipshultz LI; Hagemeister FB
J Clin Oncol; 1997 Dec; 15(12):3488-95. PubMed ID: 9396402
[TBL] [Abstract][Full Text] [Related]
10. Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome.
Ha CS; Choe JG; Kong JS; Allen PK; Oh YK; Cox JD; Edmund E
Cancer; 2000 Sep; 89(6):1371-9. PubMed ID: 11002233
[TBL] [Abstract][Full Text] [Related]
11. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
[No Abstract] [Full Text] [Related]
12. Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
Marcus KC; Kalish LA; Coleman CN; Shulman LN; Rosenthal DS; Canellos GP; Mauch PM
J Clin Oncol; 1994 Dec; 12(12):2567-72. PubMed ID: 7989930
[TBL] [Abstract][Full Text] [Related]
13. Recovery of sperm production following radiation therapy for Hodgkin's disease after induction chemotherapy with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP).
Dubey P; Wilson G; Mathur KK; Hagemeister FB; Fuller LM; Ha CS; Cox JD; Meistrich ML
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):609-17. PubMed ID: 10701740
[TBL] [Abstract][Full Text] [Related]
14. Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
Brusamolino E; Lazzarino M; Orlandi E; Canevari A; Morra E; Castelli G; Alessandrino EP; Pagnucco G; Astori C; Livraghi A
Ann Oncol; 1994; 5 Suppl 2():101-6. PubMed ID: 7515642
[TBL] [Abstract][Full Text] [Related]
15. Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie.
Raemaekers J; Burgers M; Henry-Amar M; Pinna A; Mandard A; Monfardini S; Hagenbeek A; Breed W; Carde P; Vovk M; van Hoof A; Thomas J; Noordijk E
Ann Oncol; 1997; 8 Suppl 1():111-4. PubMed ID: 9187443
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
17. Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
Bartlett NL; Rosenberg SA; Hoppe RT; Hancock SL; Horning SJ
J Clin Oncol; 1995 May; 13(5):1080-8. PubMed ID: 7537796
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease.
Loeffler M; Diehl V; Pfreundschuh M; Rühl U; Hasenclever D; Nisters-Backes H; Sieber M; Tesch H; Franklin J; Geilen W; Bartels H; Cartoni C; Dölken G; Enzian J; Fuchs R; Gassmann W; Gerhartz H; Hagen-Aukamp U; Hiller E; Hinkelbein H; Hinterberger W; Kirchner H; Koch P; Krüger B; Schwarze EW
J Clin Oncol; 1997 Jun; 15(6):2275-87. PubMed ID: 9196141
[TBL] [Abstract][Full Text] [Related]
19. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
20. Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Weiner MA; Leventhal BG; Marcus R; Brecher M; Ternberg J; Behm FG; Cantor A; Wharam M; Chauvenet A
J Clin Oncol; 1991 Sep; 9(9):1591-8. PubMed ID: 1714950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
